The effect of endothelin-1 on lipopolysaccharide-induced cyclooxygenase 2 expression in association with prostaglandin E2

European Journal of Pharmacology

Volumn 388, Issue 2, 2000, Pages 187-194

  Shimada, Keiji ^a   Kita, Taizo ^a   Yonetani, Yukio ^a   Suzumura, Akio ^a   Nakashima, Toshikatsu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Endothelin 1; Lipopolysaccharide; Macrophage; Prostaglandin E2

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; LIPOPOLYSACCHARIDE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; CYCLIC AMP; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOTHELIN-1; ENDOTOXINS; EXTRACELLULAR SPACE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; PIPERIDINES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; UP-REGULATION;

EID: 0033980115     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00847-X     Document Type: Article

References (24)

1. Chanez P., Vignola A.M., Albat B., Springall D.R., Polak J.M., Godard P., Bousquet J. Involvement of endothelin in mononuclear phagocyte inflammation in asthma. J. Allergy Clin. Immunol. 98:1996;412-420.
2. 2+ dependent pathway in OKP cells. J. Clin. Invest. 97:1996;1454-1462.
3. Coroneos E.J., Kester M., Maclouf J., Thomas P., Dunn M.J. Calcium-regulated protein tyrosine phosphorylation is required for endothelin-1 to induce prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis in mesangial cells. J. Am. Soc. Nephrol. 8:1997;1080-1090.
4. Ehrenreich H., Anderson R.W., Fox C.H., Rieckmann P., Hoffman G.S., Travis W.D., Coligan J.E., Kehrl J.H., Fauci A.S. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med. 172:1990;1741-1748.
5. A receptor- and cyclooxygenase-dependent mechanism. Br. J. Pharmacol. 118:1996;531-536.
6. Hiraki H., Hoshi N., Hasegawa H., Tanigawa T., Emura I., Saito T., Yamaki T., Fukuda T., Watanabe K., Suzuki T. Regular immunohistochemical and endothelin-B receptor in normal, hyperplastic and neoplastic human adrenocortical cells. Pathol. Int. 47:1997;117-125.
7. Inoue H., Yokoyama C., Hara S., Tone Y., Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 270:1995;24965-24971.
8. Karne S., Jayawickreme C.K., Lerner M.R. Cloning and characterization of an endothelin-3 specific receptor (ET C receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem. 268:1993;19126-19133.
9. 2 synthesis in mouse osteoblastic cells (MC3T3-E1): evidence for a protein tyrosine kinase-signaling pathway and involvement of protein kinase C. Endocrinology. 139:1998;1268-1277.
10. Mallat A., Preaux A.M., Serradeil-Le Gal C., Raufaste D., Gallois D., Brenner A., Bradham C., Maclouf J., Lourgenko V., Fouassier L., Dhumeaux D., Mavier P., Lotersztajn S. Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. J. Clin. Invest. 98:1996;2771-2778.
11. Masaki T., Yanagisawa M., Goto K. Physiology and pharmacology of endothelins. Med. Res. Rev. 12:1992;391-421.
12. Mihara S., Nakajima S., Matsumura S., Kohnoike T., Fujimoto M. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 268:1994;1122-1128.
13. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., Mahler J.F., Kluckman K.D., Ledford A., Lee C.A., Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:1995;473-482.
14. 2 in mouse bone marrow-derived mast cells. J. Biol. Chem. 269:1994;22269-22275.
15. Pang L., Hoult J.R. Induction of cyclooxygenase and nitric oxide synthase in endotoxin-activated J774 macrophages is differentially regulated by indomethacin: enhanced cyclooxygenase-2 protein expression but reduction of inducible nitric oxide synthase. Eur. J. Pharmacol. 317:1996;151-155.
16. 2 and other cyclic AMP stimulants in J774 macrophages. Biochem. Pharmacol. 53:1997;493-500.
17. Rebsamen M.C., Church D.J., Morabito D., Vallotton M.B., Lang U. Role of cAMP and calcium influx in endpothelin-1-induced ANP release in rat cardiomyocytes. Am. J. Physiol. 273:1997;E922-E931.
18. Reddy S.T., Herschman H.R. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 269:1994;15473-15480.
19. Rubanyi G.M., Polokoff M.A. Endothelin molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
20. Shimada K., Kita T., Yonetani Y., Suzumura A., Takayanagi T., Nakashima T. Modulation by endothelin-1 of lipopolysaccharide-induced cyclooxygenase 2 expression in macrophages. Eur. J. Pharmacol. 376:1999;285-292.
21. Shimada K., Yonetani Y., Kita T., Suzumura A., Takayanagi T., Nakashima T. Cyclooxygenase 2 expression by endothelin-1-stimulated mouse resident peritoneal macrophages in vitro. Eur. J. Pharmacol. 356:1998;73-80.
22. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J. Biol. Chem. 271(33157):1996.
23. Sokolovsky M. Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol. Ther. 68:1995;435-471.
24. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi Y., Mitsui M., Yasaki Y., Goto Y., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.